GB833463A - Improvements in and relating to derivatives of purine and the manufacture thereof - Google Patents
Improvements in and relating to derivatives of purine and the manufacture thereofInfo
- Publication number
- GB833463A GB833463A GB2912756A GB2912756A GB833463A GB 833463 A GB833463 A GB 833463A GB 2912756 A GB2912756 A GB 2912756A GB 2912756 A GB2912756 A GB 2912756A GB 833463 A GB833463 A GB 833463A
- Authority
- GB
- United Kingdom
- Prior art keywords
- radical
- purine
- relating
- derivatives
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention comprises compounds of the formula <FORM:0833463/IV (b)/1> (wherein X is hydrogen or an amino group and R is an acyclic radical containing only carbon, hydrogen and oxygen and having 2 to 5 carbon atoms and 1 or 2 oxygen atoms, R being attached to the adjacent sulphur atom through a carbon atom) and their preparation by reacting the corresponding 6-mercaptopurine with a halide of the radical R in the presence of an appropriate hydrohalic acid acceptor. The group R is preferably an hydroxyalkyl, oxoalkyl or carboxyalkyl radical. Examples are given.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2912756A GB833463A (en) | 1955-06-24 | 1955-06-24 | Improvements in and relating to derivatives of purine and the manufacture thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2912756A GB833463A (en) | 1955-06-24 | 1955-06-24 | Improvements in and relating to derivatives of purine and the manufacture thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
GB833463A true GB833463A (en) | 1960-04-27 |
Family
ID=10286587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2912756A Expired GB833463A (en) | 1955-06-24 | 1955-06-24 | Improvements in and relating to derivatives of purine and the manufacture thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB833463A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120207841A1 (en) * | 2004-04-01 | 2012-08-16 | Lerner E Itzhak | Formulations of 6-mercaptopurine |
US10828308B2 (en) | 2015-10-16 | 2020-11-10 | Hadasit Medical Research Services And Development Ltd. | Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine |
-
1955
- 1955-06-24 GB GB2912756A patent/GB833463A/en not_active Expired
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120207841A1 (en) * | 2004-04-01 | 2012-08-16 | Lerner E Itzhak | Formulations of 6-mercaptopurine |
US8653060B2 (en) * | 2004-04-01 | 2014-02-18 | Teva Pharmaceutical Industries Ltd. | Formulations of 6-mercaptopurine |
US9180097B2 (en) | 2004-04-01 | 2015-11-10 | Teva Pharmaceutical Industries Ltd. | Formulations of 6-mercaptopurine |
US9375403B2 (en) | 2004-04-01 | 2016-06-28 | Teva Pharmaceutical Industries Ltd. | Formulations of 6-mercaptopurine |
US10525009B2 (en) | 2004-04-01 | 2020-01-07 | Hadasit Medical Research Services And Development Ltd. | Formulations of 6-mercaptopurine |
US10828308B2 (en) | 2015-10-16 | 2020-11-10 | Hadasit Medical Research Services And Development Ltd. | Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU549117B2 (en) | Pyrimidine-2-sulphides and their 5-oxides | |
GB762257A (en) | Process for the electrodeposition of metal coatings | |
ES8200108A1 (en) | Xanthine derivatives, a process for their preparation and their use in pharmaceutical compositions. | |
GB2013192A (en) | Guanidine Derivatives, Processes for their Production and Pharmaceutical Compositions Containing Them | |
ES8101550A1 (en) | Pyrrolidine-2-methanol derivatives, process for their preparation and medicaments containing them. | |
GB833463A (en) | Improvements in and relating to derivatives of purine and the manufacture thereof | |
DK113183A (en) | CRONEETHER RELATIONSHIPS, THEIR MANUFACTURING AND USE | |
ES417828A1 (en) | Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines | |
ES360802A1 (en) | Procedure for the preparation of naftacene derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES376661A1 (en) | Phenylacetylguanidines | |
ES407730A1 (en) | Pyrimidones | |
ES389360A1 (en) | Aryloxy-and arylthioalkanoic acids and esters and salts thereof | |
ES465390A1 (en) | Diuretic and saliuretic sulphamoylbenzoic acids | |
GB713259A (en) | Improvements in or relating to processes for making derivatives of purine | |
ES435351A1 (en) | 1-(3-phenylpropyl)-4-furoylpiperazine derivatives | |
ES467744A1 (en) | Fungicide | |
ES440135A1 (en) | S-inosylcysteine and a process for producing the same | |
GB778936A (en) | Improvements relating to n-aminoalkyl derivatives of substituted iminodibenzyls | |
ES465366A2 (en) | 2-methoxybenzamides | |
ES485973A1 (en) | 3-Amino-2,4-dioxo-(1H,3H)-quinazolines, process for their preparation and therapeutic composition containing them. | |
ES383800A1 (en) | Procedure for the obtaining of pyrimidine derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES458205A1 (en) | Substituted 2-phenylimino-thiazolines and their use as ectoparasiticides | |
ES465761A1 (en) | Manufacture of 3-halosulfonylthiophene-carboxylic acid compounds | |
ES258655A1 (en) | Procedure for the preparation of new derivatives of the inmedibility (Machine-translation by Google Translate, not legally binding) | |
GB1062563A (en) | Process for preparing 1-substiuted cycloheptimidazol-2(1h)-one compounds |